Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2014

Jun 4, 2014

32414_dirs_2014-06-04_0fbe0455-373b-4de1-94a3-d18d5d0e3670.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-06-01

Reporting Person: Johnston Lee Robert Jr (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-06-01 Stock Option $2.58 A 175000 Acquired 2021-06-01 Common Stock (175000) Direct

Footnotes

F1: All shares pursuant to the options will be fully vested on June 1, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on June 1, 2015 (12 months from the option grant date) and an additional 12.5% of aggregate shares each 6 months thereafter.